Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,732
Closed -$240K 258
2024
Q1
$240K Sell
1,732
-18
-1% -$2.26K 0.01% 241
2023
Q4
$217K Buy
+1,750
New +$179K 0.01% 242
2023
Q3
Sell
-1,832
Closed -$235K 247
2023
Q2
$235K Sell
1,832
-68
-4% -$8.22K 0.02% 230
2023
Q1
$221K Sell
1,900
-12
-0.6% -$1.34K 0.01% 234
2022
Q4
$217K Buy
+1,912
New +$210K 0.01% 233
2022
Q2
Sell
-1,912
Closed -$245K 251
2022
Q1
$245K Buy
1,912
+68
+4% +$7.44K 0.02% 243
2021
Q4
$248K Sell
1,844
-40
-2% -$5.75K 0.01% 242
2021
Q3
$258K Hold
1,884
0.02% 231
2021
Q2
$201K Buy
+1,884
New +$181K 0.01% 268
2020
Q4
Sell
-2,284
Closed -$235K 242
2020
Q3
$235K Hold
2,284
0.02% 200
2020
Q2
$231K Buy
+2,284
New +$204K 0.02% 206
2018
Q4
Sell
-6,428
Closed -$230K 214
2018
Q3
$230K Buy
+6,428
New +$199K 0.02% 210

Other funds holding DXCM

1ST Source Bank's DXCM Position: Q2 2024 in Review

1ST Source Bank sold out of DexCom (DXCM) in Q2 2024, closing a stake of 1,732 shares — an estimated $240K sold.

1ST Source Bank first reported a position in DXCM in Q3 2018 and held it in 12 quarters. The position peaked at $258K in Q3 2021. 1,000 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • 1ST Source Bank reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • 1ST Source Bank sold 1,732 DexCom shares in Q2 2024, an estimated $240K.
  • 1ST Source Bank first reported a position in DexCom in Q3 2018 and held it in 12 quarters.
  • 1ST Source Bank's DexCom position peaked at $258K in Q3 2021.
  • 1,000 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on 1ST Source Bank's 13F filing for Q2 2024, filed 8 Aug 2024.